The formulation of bacteriophage in a semi solid preparation for control of propionibacterium acnes growth

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Brown, Teagan L ^a   Petrovski, Steve ^a   Dyson, Zoe A ^a   Seviour, Robert ^a   Tucci, Joseph ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; CONTROLLED STUDY; DNA BASE COMPOSITION; GENE SEQUENCE; GENOME ANALYSIS; HOST RANGE; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROPIONIBACTERIUM ACNES; SEQUENCE HOMOLOGY; SKIN FLORA; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MEDICINAL CHEMISTRY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY; SEQUENCE ALIGNMENT; SKIN; VIROLOGY;

VIRUS DNA;

BACTERIOPHAGES; BASE SEQUENCE; CHEMISTRY, PHARMACEUTICAL; DNA, VIRAL; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROPIONIBACTERIUM ACNES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SKIN;

EID: 84962519612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151184     Document Type: Article

References (52)

1. Williams HC, Dellavalle RP, Garner S (2012) Acne Vulgaris. The Lancet 379:361-372.
2. Gehse M, Hoffler U, Gloor M, Pulverer G (1983) Propionibacteria in patients with Acne vulgaris and in healthy persons. Arch Dermatol Res 275:100-104. PMID: 6223602
3. Kasimatis G, Fitz-Gibbon S, Tomida S, Wong M, Li H (2013) Analysis of complete genomes of Propionibacterium acnes reveals a novel plasmid and increased pseudogenes in an acne associated strain. Biomed Res Int 2013:918320. doi: 10.1155/2013/918320 PMID: 23762865
4. Wu J, Chantalat J, Liu JC (2015) A novel microgel complex delivers acne medicine deep into follicles while demonstrating high patient tolerance. J Drugs Dermatol 14:176-182. PMID: 25689813
5. Leyden JJ, McGinley KJ, Mills OH, Kligman AM (1975) Propionibacterium levels in patients with and without Acne vulgaris. J Inv Dermatol 65:382-384.
6. Webster GF (2002) Acne vulgaris. BMJ 325:475.
7. Brüggemann H, Henne A, Hoster F, Liesegang H, Wiezer A, et al. (2004) The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305:671-673. PMID: 15286373
8. Dessinioti C, Katsambas AD (2010) The role of Propionibacterium acnes in Acne pathogenesis: facts and controversies. Clin Dermatol 28:2-7. doi: 10.1016/j.clindermatol.2009.03.012 PMID: 20082942
9. McDowell A, Valanne S, Ramage G, Tunney MM, Glenn JV, et al. (2005) Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol 43:326-334. PMID: 15634990
10. Lomholt HB, Kilian M (2010) Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS ONE 5:e12277. doi: 10.1371/journal. pone.0012277 PMID: 20808860
11. McDowell A, Gao A, Barnard E, Fink C, Murray PI, et al. (2011) A novel multilocus sequence typing scheme for the opportunistic pathogen Propionibacterium acnes and characterization of type I cell surface-associated antigens. Microbiology 157:1990-2003. doi: 10.1099/mic.0.049676-0 PMID: 21511767
12. McDowell A, Barnard E, Nagy I, Gao A, Tomida S, et al. (2012) An expanded multilocus sequence typing scheme for Propionibacterium acnes: investigation of 'pathogenic', 'commensal'and antibiotic resistant strains. PloSONE 7:e41480. doi: 10.1371/journal.pone.0041480 PMID: 22859988
13. Scholz CF, Jensen A, Lomholt HB, Brüggemann H, Kilian M (2014) A novel high-resolution single locus sequence typing scheme for mixed populations of Propionibacterium acnes in vivo. PloS ONE 9:e104199. doi: 10.1371/journal.pone.0104199 PMID: 25111794
14. Krautheim A, Gollnick HP (2004) Acne: topical treatment. Clin Dermatol 22:398-407. PMID: 15556726
15. Brayfield A (2014) Martindale: The complete drug reference. USA: Pharmaceutical Press.
16. Ross J, Snelling A, Eady E, Cove J, Cunliffe W, et al. (2001) Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br J Dermatol 144:339-346. PMID: 11251569
17. Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, et al. (2002) Prevalence of antibiotic-resistant Propionibacteria on the skin of acne patients: 10-year surveillance data and a snapshot distribution study. Br J Dermatol 146:840-848. PMID: 12000382
18. Ross J, Snelling A, Carnegie E, Coates P, Cunliffe W, et al. (2003) Antibiotic-resistant Acne: lessons from Europe. Br J Dermatol 148:467-478. PMID: 12653738
19. Eady EA, Gloor M, Leyden JJ (2003) Propionibacterium acnes resistance: a worldwide problem. Dermatol 206:54-56.
20. Oprica C, Emtestam L, Lapins J, Borglund E, Nyberg F, et al. (2004) Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe 10:155-164. PMID: 16701513
21. Tzellos T, Zampeli V, Makrantonaki E, Zouboulis CC (2011) Treating acne with antibiotic-resistant bacterial colonization. Expert Opin Pharmacother 12:1233-1247. doi: 10.1517/14656566.2011.553192 PMID: 21355786
22. Sulakvelidze A, Alavidze Z, Morris JG Jnr. (2001) Bacteriophage Therapy. Antimicrob Agents Chemother 45:649-659. PMID: 11181338
23. Chan BK, Abedon ST, Loc-Carrillo C (2013) Phage cocktails and the future of phage therapy. Future Microbiol 8:769-783. doi: 10.2217/fmb.13.47 PMID: 23701332
24. Twort FW (1915) An investigation on the nature of ultra-microscopic viruses. The Lancet 186:1241-1243.
25. Merril CR, Scholl D, Adhya SL (2003) The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2:489-497. PMID: 12776223
26. Wei H (2015) Bacteriophages, revitalized after 100 years in the shadow of antibiotics. Virol Sin 30:1-2. doi: 10.1007/s12250-014-3562-y PMID: 25680442
27. Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1:111-114. PMID: 22334867
28. NIH (2014) NIAID's Antibacterial Resistance Program: Current Status and Future Directions. September 23rd 2015 Available: http://www.niaid.nih.gov/topics/antimicrobialresistance/documents/arstrategicplan2014.pdf
29. Markoishvili K, Tsitlanadze G, Katsarava R, Glenn J, Sulakvelidze A (2002) A novel sustained-release matrix based on biodegradable poly (ester amide) s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. IntJ Dermatol 41:453-458. PMID: 12121566
30. Jikia D, Chkhaidze N, Imedashvili E, Mgaloblishvili I, Tsitlanadze G, et al. (2005) The use of a novel biodegradable preparation capable of the sustained release of bacteriophages and ciprofloxacin, in the complex treatment of multidrug-resistant Staphylococcus aureus-infected local radiation injuries caused by exposure to Sr90. Clin Exp Dermatol 30:23-26. PMID: 15663496
31. Rhoads D, Wolcott R, Kuskowski M, Wolcott B, Ward L, et al. (2009) Bacteriophage therapy of venous Leg ulcers in humans: results of a phase I safety trial. J Wound Care 18:237-243. PMID: 19661847
32. Wright A, Hawkins C, Änggård E, Harper D (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34:349-357. doi: 10.1111/j.1749-4486.2009.01973.x PMID: 19673983
33. Soothill J (1994) Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 20:209-211. PMID: 8054131
34. Hawkins C, Harper D, Burch D, Änggård E, Soothill J (2010) Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet Microbiol 146:309-313. doi: 10.1016/j.vetmic.2010.05.014 PMID: 20627620
35. Fukuda K, Ishida W, Uchiyama J, Rashel M, Kato S-i, et al. (2012) Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration. PloS ONE 7:e47742. doi: 10.1371/journal.pone.0047742 PMID: 23082205
36. Chen L-K, Liu Y-L, Hu A, Chang K-C, Lin N-T, et al. (2013) Potential of bacteriophage 4>AB2 as an environmental biocontrol agent for the control of multidrug-resistantAcinetobacter baumannii. BMC Microbiol 13:154. doi: 10.1186/1471-2180-13-154 PMID: 23834712
37. Alfadhel M, Puapermpoonsiri U, Ford SJ, McInnes FJ, van der Walle CF (2011) Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation. Int J Pharm 416:280-287. doi: 10.1016/j.ijpharm.2011.07.006 PMID: 21771648
38. Debarbieux L, Leduc D, Maura D, Morello E, Criscuolo A, et al. (2010) Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. J Infect Dis 201:1096-1104. doi: 10.1086/651135 PMID: 20196657
39. Golshahi L, Lynch K, Dennis J, Finlay W (2011) In vitro lung delivery of bacteriophages KS4-M and 4>KZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. J Appl Microbiol 110:106-117. doi: 10.1111/j.1365-2672.2010. 04863.x PMID: 20875034
40. Farrar MD, Howson KM, Bojar RA, West D, Towler JC, et al. (2007) Genome sequence and analysis of aPropionibacterium acnes bacteriophage. J Bacteriol 189:4161-4167. PMID: 17400737
41. Lood R, Collin M (2011) Characterization and genome sequencing of two Propionibacterium acnes phages displaying pseudolysogeny. BMC Genomics 12:198. doi: 10.1186/1471-2164-12-198 PMID: 21504575
42. Marinelli LJ, Fitz-Gibbon S, Hayes C, Bowman C, Inkeles M, et al. (2012) Propionibacterium acnes Bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates. MBio 3.
43. Liu J, Yan R, Zhong Q, Ngo S, Bangayan NJ, et al. (2015) The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin. ISME J 9:2078-2093. doi: 10.1038/ismej.2015.47 PMID: 25848871
44. Petrovski S, Dyson ZA, Quill ES, McIlroy SJ, Tillett D, et al. (2011) An Examination of the Mechanisms for Stable Foam Formation in Activated Sludge Systems. Water Res 45:2146-2154. doi: 10.1016/j. watres.2010.12.026 PMID: 21239035
45. Petrovski S, Seviour RJ, Tillett D (2011) Genome sequence and characterization of the Tsukamurella bacteriophage TPA2. App Environ Microbiol 77:1389-1398.
46. Delcher AL, Harmon D, Kasif S, White O, Salzberg SL (1999) Improved microbial gene identification with GLIMMER. Nucleic Acids Res 27:4636-4641. PMID: 10556321
47. Laslett D, Canback B (2004) ARAGORN, a program to detect tRNA genes and tmRNA genes in nucleotide sequences. Nucleic Acids Res 32:11-16. PMID: 14704338
48. Schattner P, Brooks AN, Lowe TM (2005) The tRNAscan-SE, snoscan and snoGPS web servers for the detection of tRNAs and snoRNAs. Nucleic Acids Res 33:W686-W689. PMID: 15980563
49. Darling AC, Mau B, Blattner FR, Perna NT (2004) Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 14:1394-1403. PMID: 15231754
50. Allen LV (2013) Remington: An introduction to pharmacy. USA: Pharmaceutical Press.
51. Cheng X, Zhang X, Pflugrath JW, Studier FW (1994) The structure of bacteriophage T7lysozyme, a zincamidaseandan inhibitor of T7 RNA polymerase. Proc Natl Acad Sci USA 91:4034-4038. PMID: 8171031
52. Ilyina TV, Gorbalenya AE, Koonin EV (1992) Organization and evolution of bacterial and bacteriophage primase-helicase systems. J Mol Evol 34:351-357. PMID: 1569588